Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Bill & Melinda Gates Foundation and Wellcome Pledge US$300 Million to CEPI for COVID-19 Pandemic Response and to Accelerate Epidemic Preparedness 2022-01-19 07:01
CN Energy Signs Operation & Management Agreement; Enters Multi-Billion Dollar Pharmaceutical Excipients Market 2022-01-18 21:00
I-Mab Announces First Patient Dosed in China Phase 2 Combination Trial of Lemzoparlimab with Toripalimab in Patients with Advanced Solid Tumors 2022-01-18 21:00
Ascletis Announces Signing of Ritonavir Tablet Purchase Agreement with Phokam Pharmaceutical Import-Export Co., Ltd of Laos 2022-01-18 18:00
Menarini Diagnostics CoronaMeltVAR Real-Time PCR kit simultaneously detects SARS CoV-2 and identifies the Omicron Variant 2022-01-17 22:12
Seegene's Allplex™ SARS CoV-2 FluA/FluB/RSV Assay approved under Health Canada's Interim Order 2022-01-17 20:00
Seegene Continues to Support Israel's Effort to Manage the Omicron Variant With Timely Delivery of Five Million Tests 2022-01-17 20:00
Ascletis Announces U.S. IND Approval of ASC22 (Envafolimab), a Subcutaneously Administered PD-L1 Antibody for Functional Cure of Chronic Hepatitis B 2022-01-17 18:12
Frost & Sullivan and TERI's Sustainability 4.0 Awards 2021 Honor Companies Embedding Sustainability with Economic Value Creation 2022-01-17 17:30
The Philippines Has Approved ReCOV For Phase II/III Cinical Trial 2022-01-17 16:57
Xinhua Silk Road: BGI Genomics' star COVID-testing mobile lab product exhibited at China Pavilion of Expo 2020 Dubai 2022-01-17 10:22
Crunchfish Gesture Interaction introduction - Deeply intuitive gestures 2022-01-14 19:17
Everest Medicines Enters into a Global Licensing Agreement to Develop and Commercialize Singapore's Experimental Drug Development Centre's 3CL Protease Inhibitors as Potentially Best-in-Class COVID-19 Oral Antiviral Treatments Worldwide 2022-01-14 08:00
Ascletis Announces First Patient Dosed in the Phase II Clinical Trial of FASN Inhibitor ASC40 for Treatment of Moderate to Severe Acne 2022-01-13 17:30
Apex Medical Rebrands to Wellell, redefining core values 2022-01-13 16:00
Enrollment Completed in Phase II Clinical Study of KN026 Combined with KN046 2022-01-13 10:46
Seegene Unveils Blueprint for the Future of Molecular Diagnostics, Including Open Development Platform at the 40th Annual J.P. Morgan Healthcare Conference 2022-01-13 04:00
I-Mab Announces First Patient Dosed in China Phase 2 Clinical Trial of Efineptakin Alfa in Combination with Pembrolizumab in Advanced Solid Tumors 2022-01-12 21:00
Singapore biotech firm JN Medsys develops a PCR test kit that specifically detects for the Omicron variant with high accuracy 2022-01-12 18:18
BGI Genomics, Chinese gene test company, showcases high-throughput COVID testing air lab at Dubai World Expo 2022-01-12 17:18
1 59 60 61 62 63 229